C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 19/00 (2006.01)
Patent
CA 2531412
An improved process for the preparation of 2'-modified nucleosides and 2'- deoxy-nucleosides, such as, .beta.-L-2'-deoxy-thymidine (LdT), is provided. In particular, the improved process is directed to the synthesis of a 2'- deoxynucleoside that may utilize different starting materials but that proceeds via a chloro-sugar intermediate or via a 2,2'~ anhydro-1-furanosyl- nucleobase intermediate. Where an 2,2'-anhydro-1-furanosyl base intermediate is utilized, a reducing agent, such as Red-Al, and a sequestering agent, such as 15-crown-5 ether, that cause an intramolecular displacement reaction and formation of the desired nucleoside product in good yields are employed. An alternative process of the present invention utilizes a 2,2'-anhydro-1- furanosyl base intermediate without a sequestering agent to afford 2'- deoxynucleosides in good yields. The compounds made according to the present invention may be used as intermediates in the preparation of other nucleoside analogues, or may be used directly as antiviral and/or antineoplastic agents.
Cette invention concerne une technique améliorée de préparation de nucléosides modifiés en 2' et de nucléosides 2'-désoxy, tels que la .szlig.-L-2'-désoxy-thymidine (LdT). Cette technique concerne en particulier la synthèse d'un nucléoside 2'-désoxy qui peut utiliser différents matériaux de départ, mais qui se fait via un intermédiaire de chloro-sucre ou un intermédiaire d'une nucléobase de 2,2'- anhydro-1-furanosyle. Dans le cas d'un intermédiaire d'une base de 2,2'-anhydro-1-furanosyle, on utilise un agent réducteur tel que Red-Al, et un agent séquestrant tel qu'un éther15-couronne-5 qui provoquent une réaction de déplacement intramoléculaire et la formation abondante du produit nucléosidique recherché. En variante, on peut utiliser un intermédiaire de base 2,2'-anhydro-1-furanosyle sans agent séquestrant pour obtenir de bons rendements de 2'-désoxy nucléosides. Les composés obtenus selon la présente invention peuvent être utilisés comme intermédiaires pour l'obtention d'autres analogues de nucléosides, ou bien directement en tant qu'agents antiviraux et/ou anti-néoplasiques.
Chaudhuri Narayan
Mathieu Steven
Moussa Adel
Stewart Alistair
Storer Richard
Idenix (cayman) Limited
Mbm Intellectual Property Law Llp
Novartis Ag
LandOfFree
Synthesis of .beta.-l-2'-deoxy nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthesis of .beta.-l-2'-deoxy nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis of .beta.-l-2'-deoxy nucleosides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1817544